Companies /Healthcare
Natera Inc
NASDAQ: NTRA Diagnostics & Research
$403.95
▲ $2.58 (+0.64%) today
Markets closed · 3:02pm ET

Natera (NTRA) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
33%
EPS beat rate
−43.74%
Avg. EPS surprise
Consecutive EPS beats
NTRA vs Market · 30-day return after each reportNTRAS&P 500
0%+7%+14%+9.8%+6.6%Q1 25+11.7%+2.4%Q2 25+16.8%+2.5%Q3 25−3.9%−5.2%Q4 25+11.5%−1.7%Q1 26+2.6%−1.4%Q2 26
0%+7%+14%Q1 25Q3 25Q1 26
NTRA EPS Trend · estimate vs actualEstimateActual
$-1.50$-1.00$-0.50$-0.66$-0.50Q1 25$-0.59$-0.74Q2 25$-0.35$-0.64Q3 25$-0.53$-1.52Q4 25$-0.55$-0.60Q1 26$-0.53$-0.47Q2 26
$-1.50$-1.00$-0.50Q1 25Q3 25Q1 26
NTRA Revenue Trend · estimate vs actualEstimateActual
$0$300.0M$600.0M$446.7M$501.8MQ1 25$476.8M$546.6MQ2 25$514.8M$592.2MQ3 25$600.7M$665.5MQ4 25$617.1M$696.6MQ1 26$661.3M$752.8MQ2 26
$0$300.0M$600.0MQ1 25Q3 25Q1 26

How Often Does Natera Beat Earnings Estimates?

Natera beat EPS estimates in 2 of its last 6 reported quarters.

NTRA quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.47 est. $-0.53 +11.99% $752.8M est. $661.3M +13.83%
Q1 2026 $-0.60 est. $-0.55 −8.52% $696.6M est. $617.1M +12.90%
Q4 2025 $-1.52 est. $-0.53 −184.80% $665.5M est. $600.7M +10.79%
Q3 2025 $-0.64 est. $-0.35 −80.74% $592.2M est. $514.8M +15.04%
Q2 2025 $-0.74 est. $-0.59 −24.54% $546.6M est. $476.8M +14.63%
Q1 2025 $-0.50 est. $-0.66 +24.17% $501.8M est. $446.7M +12.35%

Figures from SEC filings and company reports. Not investment advice.